Effects of Maxacalcitol on Bone Metabolic Markers in Hemodialysis Patients With Secondary Hyperparathyroidism

Nihon Toseki Igakkai Zasshi
doi 10.4009/jsdt.37.1503
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society for Dialysis Therapy

Related search

The Effects of Maxacalcitol Therapy for the Patients With Secondary Hyperparathyroidism on Clinical Symptoms, Bone Mineral Density and Parathyroid Swelling

Nihon Toseki Igakkai Zasshi
2007English

Nutritional Status of Hemodialysis Patients With Secondary Hyperparathyroidism

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2000English

Effect of 22-Oxacalcitriol on Secondary Hyperparathyroidism in Hemodialysis Patients

Internal Medicine
Internal MedicineMedicine
2003English

Erratum To: Calcitriol Resistance in Hemodialysis Patients With Secondary Hyperparathyroidism

International Urology and Nephrology
UrologyNephrology
2014English

PTH-dependence of the Effectiveness of Cinacalcet in Hemodialysis Patients With Secondary Hyperparathyroidism

Scientific Reports
Multidisciplinary
2016English

Clinical Efficacy of 22-Oxacalcitriol Against Secondary Hyperparathyroidism in Hemodialysis Patients.

Nihon Toseki Igakkai Zasshi
1999English

Parathyroidectomy Can Improve Bone Mineral Density in Patients With Symptomatic Secondary Hyperparathyroidism

Archives of Surgery
2001English

Leontiasis Ossea Following Secondary Hyperparathyroidism and Hemodialysis

Journal of Biosciences and Medicines
2015English

Intermittent Dosing of Cinacalcet Is Also Effective in Treating Secondary Hyperparathyroidism in Hemodialysis Patients

Pharmaceutica Analytica Acta
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy